Scl1-mediated immune evasion of the rheumatologenic group A Streptococcus
Scl1-mediated immune evasion of the rheumatologenic group A Streptococcus
批准号:
8104020
负责人:
Slawomir Lukomski
金额:
$21.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-05 至 2014-06-30
关键词:
AcuteAffectAntibodiesAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBacteriaBenignBindingBiological AssayBloodBrainCell Surface ProteinsCell surfaceCellsCollagenCollagen DiseasesComplementComplement 3bComplement ActivationComplement Factor HConnective TissueDepositionDiseaseDisease ProgressionDissectionEventFlow CytometryFluorescence MicroscopyGeneticGlomerulonephritisGoalsHeartHemolytic-Uremic SyndromeHumanImmuneImmune responseImmune systemImmunoassayIn VitroInfectionInfectious Skin DiseasesInflammatoryInterventionInvestigationJointsLifeLigandsMediatingMembrane ProteinsMolecular MimicryMusMutationNatural ImmunityPathogenesisPathologistPatientsPhagocytosisPharyngeal structurePlasmaPlayProteinsPublic HealthRecombinantsResearchRheumatic FeverRheumatologic DisorderRoleSerumStreptococcal InfectionsStreptococcus pyogenesSurfaceWorkcombatcross reactivitygenetic regulatory proteinhuman morbidityhuman mortalityin vitro Modelin vivokillingsmutantnanocrystalneutrophilpreventpublic health relevancesynthetic peptide
中文摘要
描述(由申请人提供):A群链球菌(GAS)引起良性到危及生命的感染,也可以引发自身免疫性疾病,包括急性风湿热。详细了解GAS避免被宿主免疫系统杀死并定植宿主的机制以及鉴定交叉反应性GAS抗原对于成功对抗链球菌感染至关重要。因此,长期目标是确定链球菌胶原样蛋白1 (Scl1)是一种不可或缺的辅助蛋白,它有助于风湿性m6型GAS的发病机制,从而诱导抗胶原自身免疫。这一应用主要集中在Scl1在免疫逃避中的作用,作为发病机制的第一步。本应用程序的目的是确定因子H与GAS细胞上的天然Scl1结合的机制,并确定Scl1-因子H相互作用在人血液中GAS存活和小鼠发病中的重要性。我们提出了两个具体目标:(1)表征天然Scl1蛋白与正常和异常因子H的相互作用,并确定sc1蛋白结合因子H在补体介导的GAS逃逸中的作用;(2)证明小鼠感染过程中scl1因子H的相互作用会加速疾病进展。基因解剖、体外结合和功能分析,以及使用正常小鼠和因子h耗尽小鼠进行体内研究的结合将用于实现这些目标。我们假设scl是主要的因子h结合分子,它是充分保护m6型GAS免受补体介导的调理和体外吞噬所必需的。此外,我们还提出体内Scl1结合因子H可提高小鼠体内GAS的存活和感染传播。该研究有望证明Scl1是GAS免疫逃避的主要决定因素。与公共卫生相关:拟议的调查将填补我们对GAS免疫逃避机制理解的关键空白。针对这些机制可能是对抗GAS感染的有效策略。
英文摘要
DESCRIPTION (provided by applicant): Group A Streptococcus (GAS) causes benign to life-threatening infections that can also trigger autoimmune diseases, including acute rheumatic fever. A detailed understanding of the mechanisms by which GAS avoids killing by the host immune system to colonize the host and identifying cross-reactive GAS antigens is critical for a successful combating of streptococcal infections. Thus, the long-term objective is to determine that the streptococcal collagen-like protein 1 (Scl1) is an indispensable accessory protein, which is instrumental to the pathogenesis of rheumatogenic M6-type GAS that leads to induction of anti-collagen autoimmunity. This application is focused on the role of Scl1 in immune evasion as an initial step in pathogenesis. The objectives of this application are to define the mechanism of factor H binding to native Scl1 on GAS cells, and to determine the importance of Scl1-factor H interaction in GAS survival in human blood, and in the pathogenesis in mice. We propose two specific aims: (1) To characterize the interactions of native Scl1 protein with normal and abnormal factor H, and to define the role of factor H binding by the Scl1 protein in GAS escape from complement-mediated destruction; and (2) To demonstrate that Scl1-factor H interaction during mouse infection augments disease progression. A combination of genetic dissection, in vitro binding and functional assays, and in vivo studies using normal and factor H-depleted mice will be used to accomplish these goals. We hypothesize that Scl1 is the major factor H-binding molecule that is necessary for the full protection of the M6-type GAS from complement-mediated opsonization and phagocytosis in vitro. In addition, we also propose that factor H binding by Scl1 in vivo enhances GAS survival and infection dissemination in mice. The proposed study is expected to demonstrate that Scl1 is major determinant of GAS immune evasion. Relevance to public health: The proposed investigations will fill a critical gap in our understanding of the mechanisms of GAS immune evasion. Targeting these mechanisms could be an effective strategy against GAS infections.
PUBLIC HEALTH RELEVANCE: Group A streptococcal (GAS) infections are responsible for significant human morbidity and mortality worldwide but there are no effective strategies for global intervention. GAS cells contain surface proteins that are important for pathogenesis. The objective of our research is to characterize the role of a cell surface protein, called Scl1, in GAS immune evasion. Our studies will contribute towards understanding some of the mechanisms by which these bacteria survive human immune responses and produce disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
链球菌胶原蛋白样蛋白 1 (Scl1) 通过其保守的 C 末端与人类补体调节因子 CFHR1 和 H 因子结合,从而可以在多个水平上控制补体级联。
DOI:
10.1074/jbc.m110.143727
发表时间:
2010
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Reuter,Michael, Caswell,ClaytonC, Lukomski,Slawomir, Zipfel,PeterF]
通讯作者:
Zipfel,PeterF
Scl1-mediated immune evasion of the rheumatologenic group A Streptococcus
-
批准号:7896096
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2010
-
负责人:Slawomir Lukomski
-
依托单位:
Sc1 Proteins of S pyogenes: Biology and Function
-
批准号:6739013
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2003
-
负责人:Slawomir Lukomski
-
依托单位:
Sc1 Proteins of S pyogenes: Biology and Function
-
批准号:6755777
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2003
-
负责人:Slawomir Lukomski
-
依托单位:
Sc1 Proteins of S pyogenes: Biology and Function
-
批准号:6893416
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2003
-
负责人:Slawomir Lukomski
-
依托单位:
Sc1 Proteins of S pyogenes: Biology and Function
-
批准号:6620333
-
项目类别:
-
资助金额:$4.06万
-
财政年份:2002
-
负责人:Slawomir Lukomski
-
依托单位:
Sc1 Proteins of S pyogenes: Biology and Function
-
批准号:6415733
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2002
-
负责人:Slawomir Lukomski
-
依托单位:
海外基金